• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A SAS/IML program for simulating pharmacokinetic data.

作者信息

Russek-Cohen Estelle, Martinez Marilyn N, Nevius Anna B

机构信息

Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA.

出版信息

Comput Methods Programs Biomed. 2005 Apr;78(1):39-60. doi: 10.1016/j.cmpb.2004.10.007.

DOI:10.1016/j.cmpb.2004.10.007
PMID:15780889
Abstract

Data simulation can be an invaluable tool for optimizing the design of bioequivalence trials. It can be particularly useful when exploring alternative approaches for assessing product comparability especially in the context of encountering various complex experimental situations that can occur in veterinary medicine. With this in mind, we designed a novel SAS/IML program to generate pharmacokinetic datasets that reflect the various kinetic, population, and study design characteristics that complicate the bioequivalence evaluation of animal health products. Developing this simulation program within SAS provides an opportunity to utilize the statistical capabilities of this software platform.

摘要

相似文献

1
A SAS/IML program for simulating pharmacokinetic data.
Comput Methods Programs Biomed. 2005 Apr;78(1):39-60. doi: 10.1016/j.cmpb.2004.10.007.
2
Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs.关于口服药物单指数终末相标准化识别的提议。
Biopharm Drug Dispos. 2008 Apr;29(3):145-57. doi: 10.1002/bdd.596.
3
Current challenges facing the determination of product bioequivalence in veterinary medicine.兽医学中产品生物等效性测定面临的当前挑战。
J Vet Pharmacol Ther. 2010 Oct;33(5):418-33. doi: 10.1111/j.1365-2885.2010.01180.x.
4
Estimating product bioequivalence for highly variable veterinary drugs.评估高变异性兽药的产品生物等效性。
J Vet Pharmacol Ther. 2012 Apr;35 Suppl 1:11-6. doi: 10.1111/j.1365-2885.2012.01376.x.
5
Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).生物等效性试验的计算机模拟:具有首过肝代谢的BCS药物中设计和分析物的选择:线性动力学(I)
Eur J Pharm Sci. 2009 Jan 31;36(1):137-46. doi: 10.1016/j.ejps.2008.10.014. Epub 2008 Nov 5.
6
Bioavailability and bioequivalence trials: statistics & pharmacokinetic principles.生物利用度与生物等效性试验:统计学与药代动力学原理
Stud Health Technol Inform. 2004;103:159-79.
7
Demonstrating bioequivalence using clinical endpoint studies.使用临床终点研究证明生物等效性。
J Vet Pharmacol Ther. 2012 Apr;35 Suppl 1:31-7. doi: 10.1111/j.1365-2885.2012.01366.x.
8
Considerations for extrapolating in vivo bioequivalence data across species and routes.跨物种和给药途径外推体内生物等效性数据的考量因素。
J Vet Pharmacol Ther. 2012 Apr;35 Suppl 1:45-52. doi: 10.1111/j.1365-2885.2012.01365.x.
9
Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination.立体异构药物的药代动力学和药效学,尤其涉及生物等效性测定。
J Vet Pharmacol Ther. 2012 Apr;35 Suppl 1:17-29. doi: 10.1111/j.1365-2885.2012.01367.x.
10
The 2010 AAVPT/EAVPT/ECVPT bioequivalence workshop.2010年腺相关病毒载体生产技术/欧洲腺相关病毒载体生产技术/欧洲细胞与基因治疗学会生物等效性研讨会
J Vet Pharmacol Ther. 2011 Apr;34(2):105-7. doi: 10.1111/j.1365-2885.2011.01281.x. Epub 2011 Feb 17.